Answers are grounded in this paper and cite their sources.
Demonstrates C–H arylation in imidazo[1,2-a]pyridines and zolimidines, indicating a promising catalyst for pharmaceutical applications.
Tripalladium cluster [Pd3]+-1-3 (0.33 mol %) presented superior reactivity in the C-H arylation of imidazo[1,2-a]pyridines and zolimidines with aryl halides compared to palladium monomers and nanoparticles, affording important imidazole[1,2-a]pyridine and zolimidine derivatives that featured excellent fluorescent and pharmaceutical properties. This method highlights the low catalyst usage, mild conditions, scale-up practicality, and broad substrate scope. Mechanistic and kinetic analyses indicated that [Pd₃]⁺ most likely remained intact throughout this synergistic catalytic process.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: